References | Journal | Year | |
Pharmacological characterization of 1-(5-chloro-6-(trifluoromethoxy)-1H-benzoimidazol-2-yl)-1H-pyrazole-4-carboxylic acid (JNJ-42041935), a potent and selective hypoxia-inducible factor prolyl hydroxylase inhibitor. Barrett, T.D., Palomino, H.L., Brondstetter, T.I., Kanelakis, K.C., Wu, X., Haug, P.V., Yan, W., Young, A., Hua, H., Hart, J.C., Tran, D.T., Venkatesan, H., Rosen, M.D., Peltier, H.M., Sepassi, K., Rizzolio, M.C., Bembenek, S.D., Mirzadegan, T., Rabinowitz, M.H., Shankley, N.P. | Mol Pharmacol. | 2011 | View |
Association between synovial fluid levels of aggrecan ARGS fragments and radiographic progression in knee osteoarthritis. Larsson S, Englund M, Struglics A, Lohmander LS. | Arthritis Res Ther. | 2010 | View |
Cerebrospinal fluid inflammatory cytokines and biomarkers of injury severity in acute human spinal cord injury. Kwon, B.K., Stammers, A.M., Belanger, L.M., Bernardo, A., Chan, D., Bishop, C.M., Slobogean, G.P., Zhang, H., Umedaly, H., Giffin, M., Street, J., Boyd, M.C., Paquette, S.J., Fisher, C.G., Dvorak, M.F. | J Neurotrauma. | 2010 | View |
Effect of pazopanib on tumor microenvironment and liposome delivery. Tailor, T.D., Hanna, G., Yarmolenko, P.S., Dreher, M.R., Betof, A.S., Nixon, A.B., Spasojevic, I., Dewhirst, M.W. | Mol Cancer Ther. | 2010 | View |
First missense mutation in the SOST gene causing sclerosteosis by loss of sclerostin function. Piters E, Culha C, Moester M, Van Bezooijen R, Adriaensen D, Mueller T, Weidauer S, Jennes K, de Freitas F, Lowik C, Timmermans JP, Van Hul W, Papapoulos S. | Hum Mutat. | 2010 | View |
Identification and inhibition of drug target interference in immunogenicity assays. Zhong, Z.D., Dinnogen, S., Hokom, M., Ray, C., Weinreich, D., Swanson, S.J., Chirmule, N. | Journal of Immunological Methods | 2010 | View |
Pharmacology and placental transfer of a human av integrin monoclonal antibody in rabbits. Martin, P. L., Zhou, Z., Van den Bulck, K., Kwok, D., Powers, G., Jiao, Q., Schantz, A., Treacy, G. | Birth Defects Res B Dev Reprod Toxicol. | 2010 | View |
Phase 1 study of the investigational, oral angiogenesis inhibitor motesanib in Japanese patients with advanced solid tumors. Fujisaka, Y., Yamada, Y., Yamamoto, N., Shimizu, T., Fujiwara, Y., Yamada, K., Tamura, T., Watanabe, H., Sun, Y.N., Bass, M.B., Seki, M. | Cancer Chemother Pharmacol. | 2010 | View |
Placental growth factor neutralising antibodies give limited anti-angiogenic effects in an in vitro organotypic angiogenesis model. Brave, S.R., Eberlein, C., Shibuya, M., Wedge, S.R., Barry, S.T. | Angiogenesis. | 2010 | View |
The application of target information and preclinical pharmacokinetic/pharmacodynamic modeling in predicting clinical doses of a Dickkopf-1 antibody for osteoporosis. Betts, A.M., Clark, T.H., Yang, J., Treadway, J.L., Li, M., Giovanelli, M.A., Abdiche, Y., Stone, D.M., Paralkar, V.M. | J Pharmacol Exp Ther. | 2010 | View |
Transcriptional responses in the adaptation to ischaemia-reperfusion injury: a study of the effect of ischaemic preconditioning in total knee arthroplasty patients. Murphy, T., Walsh, P.M., Doran, P.P., Mulhall, K.J. | J Transl Med. | 2010 | View |
Circulating Transforming Growth Factor-ß in Marfan Syndrome. Matt, P., Schoenhoff, F., Habashi, J., Holm, T., Van Erp, C., Loch, D., Carlson, O.D., Griswold, B.F., Fu, Q., Backer, J.D., PhD, Loey, B., Huso, D.L., McDonnell, N.B., Van Eyk, J.E., Dietz, H.C. | Journal of American Heart Association. | 2009 | View |
Electrochemiluminescent immunoassay for rat skeletal troponin I (Tnni2) in serum. Sun, D., Hamlin, D., Butterfield, A., Watson, D.E., Smith, H.W. | J Pharmacol Toxicol Methods. | 2009 | View |
Nox4 mediates the expression of plasminogen activator inhibitor-1 via p38 MAPK pathway in cultured human endothelial cells. Jaulmes, A., Sansilvestri-Morel, P., Rolland-Valognes, G., Bernhardt, F., Gaertner, R., Lockhart, B.P., Cordi, A., Wierzbicki, M., Rupin, A., Verbeuren, T.J. | Thromb Res. | 2009 | View |
The hydrophobic tunnel present in LOX-1 is essential for oxidized Low-density lipoprotein recognition and binding. Francone, O.L., Tu, M., Royer, L.J., Zhu, J., Stevens, K., Oleynek, J.J., Lin, Z., Shelley, L., Sand, T., Luo, Y., Kane, C.D. | J Lipid Res. | 2009 | View |
Novel technologies for the discovery and quantitation of biomarkers of toxicity. Collings, F.B., Vaidya, V.S. | Toxicology. | 2008 | View |
SB-267268, a Nonpeptidic Antagonist of vß3 and vß5 Integrins, Reduces Angiogenesis and VEGF Expression in a Mouse Model of Retinopathy of Prematurity. Wilkinson-Berka, J. L., Jones, D., Taylor, G., Jaworski, K., Kelly, D. J., Ludbrook, S. B., Willette, R. N., Kumar, S., Gilbert, R.E. | Invest Ophthalmol Vis Sci. | 2006 | View |